WordNet

(mechanics) the equal and opposite force that is produced when any force is applied to a body; "every action has an equal and opposite reaction"
a response that reveals a persons feelings or attitude; "he was pleased by the audiences reaction to his performance"; "John feared his mothers reaction when she saw the broken lamp"
a bodily process occurring due to the effect of some antecedent stimulus or agent; "a bad reaction to the medicine"; "his responses have slowed with age" (同)response
doing something in opposition to another way of doing it that you dont like; "his style of painting was a reaction against cubism"
an idea evoked by some experience; "his reaction to the news was to start planning what to do"
extreme conservatism in political or social matters; "the forces of reaction carried the election"

PrepTutorEJDIC

{名}(…に対する)『反応』《+『to』+『名』》 / 〈U〉(…に対する)(政治的・社会的な)『反動』,逆コース《+『against』+『名』》 / 〈U〉〈C〉化学反応,化学変化 / 〈U〉〈C〉(物理学で)反作用

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 急性リンパ芽球性白血病における微小残存病変の検出 detection of minimal residual disease in acute lymphoblastic leukemia
2. 急性骨髄性白血病における寛解基準および残存病変のモニタリング remission criteria in acute myeloid leukemia and monitoring for residual disease
3. 薬物アレルギー：分類および臨床的特徴 drug allergy classification and clinical features
4. 分子標的剤およびその他の生物製剤を用いた癌治療による皮膚合併症 cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy
5. 急性リンパ芽球性白血病における微小残存病変の検出方法の臨床使用 clinical use of minimal residual disease detection in acute lymphoblastic leukemia

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity.

Oancea I, Png CW, Das I, Lourie R, Winkler IG, Eri R, Subramaniam N, Jinnah HA, McWhinney BC, Levesque JP, McGuckin MA, Duley JA, Florin TH.SourceUQ Department of Medicine, Mater Adult Hospital, South Brisbane, QLD 4101, Australia; t.florin@uq.edu.au.
Gut.Gut.2013 Apr;62(4):594-605. doi: 10.1136/gutjnl-2012-302274. Epub 2012 Jul 7.
OBJECTIVE: The anti-leukemic drugs, azathioprine and 6-mercaptopurine (6MP), are important in the treatment of inflammatory bowel disease but an alternative faster-acting, less-allergenic thiopurine, 6-thioguanine (6TG), can cause hepatic veno-occlusive disease/sinusoidal obstructive syndrome (SOS).
PMID 22773547

Chaber R, Fiszer-Maliszewska L, Noworolska-Sauren D, Kwasnicka J, Wrobel G, Chybicka A.Source*Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University †Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland.
Journal of pediatric hematology/oncology.J Pediatr Hematol Oncol.2013 Apr;35(3):180-7. doi: 10.1097/MPH.0b013e318286d29b.
The BCL-2 protein plays an important role in controlling apoptosis. Disorders of this process can lead to the emergence and development of acute lymphoblastic leukemia (ALL) and can determine the resistance of leukemic cells to chemotherapy. The levels of BCL-2 mRNA were determined in 20 children wi
PMID 23511489

The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells.

Shen FH, Jin J, Li J, Wang Y, Zhu SH, Lu YJ, Ou TM, Huang ZS, Huang M, Huang ZY.SourceCenter of Preclinical Screening and Evaluation on New Drug, School of Pharmaceutical Sciences, Sun Yat-sen University , Guangzhou , PR China.
Pharmaceutical biology.Pharm Biol.2013 Apr;51(4):447-54. doi: 10.3109/13880209.2012.738424. Epub 2013 Jan 30.
Context: N'-(7-Fluoro-5-N-methyl-10H-indolo[3,2-b]quinolin-5-ium)-N,N-dimethylpropane-1,3-diamine iodide (SYUIQ-FM05) is a semi-synthetic derivative of cryptolepine which is from Cryptolepis sanguinolenta (Lindl.) Schlechter (Periplocaeae). This ligand inhibits telomerase activity by stabilizing the
PMID 23363047

Systemic Follicular Lymphoma with Massive Intestinal Involvement with Leukemic Manifestation

ONO Yuichiro,AOKI Kazunari,KATO Aiko,ARIMA Hiroshi,TAKIUCHI Yohko,NAGANO Seiji,TABATA Sumie,YANAGITA Sohshi,MATSUSHITA Akiko,MARUOKA Hayato,IMAI Yukihiro,ISHIKAWA Takayuki,TAKAHASHI Takayuki
Journal of clinical and experimental hematopathology 51(2), 135-140, 2011-11-01
… Polymerase chain reaction analysis of cells from peripheral blood, bone marrow, and intestinal lesion showed a fusion product of <I>BCL2</I> … A diagnosis of follicular lymphoma with massive intestinal involvement in a leukemic state was made. …
NAID 10030207699

北川好郎
愛知医科大学医学会雑誌 34(2/3/4), 71-80, 2006-12-15
… Recently, minimal residual disease (MRD) measured by polymerase chain reaction (PCR) has been utilized to evaluate the response to initial treatment in these patients. … DNA of leukemic cells was extracted from patients' bone marrow. …
NAID 110006425896

Myelofibrosis with Myeloid Metaplasia : New Developments in Pathogenesis and Treatment

Dingli David,Mesa Ruben A.,Tefferi Ayalew
Internal medicine 43(7), 540-547, 2004-07-01
… Myeloid metaplasia with myelofibrosis (MMM) is a chronic myeloproliferative disorder (CMPD) characterized by progressive anemia, massive splenomegaly, both hepatosplenic and non-hepatosplenic extramedullary hematopoiesis (EMH), a leukoerythroblastic blood smear, circulating progenitor cells, and marked bone marrow stromal reaction including collagen fibrosis, osteosclerosis and angiogenesis. … Death is often due to leukemic transformation, portal hypertension or infection. …
NAID 10013349780